Purdue Pharma’s $7.4 Billion Chapter 11 Plan Formally Approved
A federal bankruptcy court on November 18 formally approved Purdue’s $7.4 billion Chapter 11 plan to settle thousands of opioid-related lawsuits. The plan requires (1) a $6.5 billion contribution from...
Vertical Aerospace Poised for Piloted Transition Amid Expanding eVTOL Market
Vertical Aerospace (NYSE: EVTL) achieved a milestone in its eVTOL (electric vertical take-off and landing vehicle) development. On November 13, 2025, the UK Civil Aviation Authority (CAA) granted Vertical a...
Steve Jensen and Joseph Re Again Named to OC500 List by Orange County Business Journal
IRVINE, Calif., November 19, 2025 – Knobbe Martens is proud to share that for the second consecutive year, partners Steve Jensen and Joseph Re have been named to the OC500, Orange County Business Journal’s annual...
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case
IRVINE, Calif., November 17, 2025 – A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo’s patented heart...
U.S. Government Aerospace Procurement Updates and Implications for Intellectual Property
The U.S. government has recently signaled changes for development and procurement of weapons and aerospace systems. The government has stressed moving faster in procurement and becoming more self-reliant in manufacturing...
Missing the (Lex)Mark – What Is the Proper Standing Test Before the USPTO?
Following a Trademark Trial and Appeal Board (TTAB) decision and corresponding Federal Circuit appeal finding that she did not have standing to oppose registration of a RAPUNZEL mark for dolls,...
Volunteer Legal Advocates Honors Ari Feinstein for Pro Bono Work Supporting Domestic Violence Victims
WASHINGTON, D.C., November 14, 2025 – Knobbe Martens is proud to share that partner Ari Feinstein has received the “Civil Protection Order Volunteer of the Year” recognition from Volunteer Legal...
Director Discretion: A Sotera Stipulation Does Not Mandate Institution
In Re MOTOROLA SOLUTIONS, INC. Before Dyk, Linn, and Cunningham Summary: The PTO Director has unreviewable discretion to deny institution of IPR proceedings in view of parallel proceedings, even when...
Nothing Unusual With Recusal Refusal
Centripetal Networks, LLC, v. Palo Alto Networks, Inc. Before Moore, Hughes, and Cunningham. Appeal from the Patent Trial and Appeal Board. Summary: Despite affirming the denial of Centripetal’s recusal motion...
Green With Envy: When Your Color Trademark Turns Out to Be Generic
PT Medisafe Technologies (“Medisafe”) has petitioned the U.S. Supreme Court to review a Federal Circuit decision upholding the Trademark Trial and Appeal Board’s (“TTAB”) refusal to register Medisafe’s dark green...
PTAB Update | October 2025
USPTO Proposes Rule and Director Implements Policy Likely to Limit Multiple Patent Validity Challenges Ted M. Cannon On Friday, October 17, the USPTO published a proposed rule that, if implemented, would likely...
Federal Circuit Review | October 2025
October Federal Circuit Newsletter (Japanese) October Federal Circuit Newsletter (Chinese) Standing or Guesswork? A Speculative Risk of Patent Cancellation is Insufficient for Standing In Us Inventor, Inc. v. United...
Aerospace Update | October 2025
NASA’s Breakthrough Superalloy Wins Commercial Invention of the Year Ningxi Sun NASA Glenn Research Center’s new material, GRX-810, has been recognized as the Commercial Invention of the Year by NASA’s Inventions and Contributions...
Litigation Update | October 2025
Standing or Guesswork? A Speculative Risk of Patent Cancellation is Insufficient for Standing Jacob R. Rosenbaum & Jordan A. DeOrio US INVENTOR, INC. v. UNITED STATES PATENT AND TRADEMARK OFFICE Before Lourie, Reyna,...
Life Science Update | October 2025
USPTO, JPO, and EPO Meet to Discuss Global IP Challenges Joseph Mallon, Ph.D. & Ashley C. Morales Beginning on October 20, 2025, recently confirmed United States Patent and Trademark Office (USPTO) Director...
In Federal News Network Interview, Jarom Kesler Discusses Impact of Government Shutdown on IP and Patent Litigation
In a recent interview with Federal News Network, Knobbe Martens partner Jarom Kesler provided insights into the impact of the government shutdown on intellectual property law, including how the United...
Knobbe Martens Recognized Among Top-Tier Firms in Best Law Firms Annual Guide
Firm receives ‘Tier 1’ national and regional rankings for litigation, patent and trademark work IRVINE, Calif., November 6, 2025 – Knobbe Martens has once again been recognized as a top-tier...
Aerospace IP Strategy in View of Recent U.S. Patent Office Updates
Aerospace technology companies often decide between patenting an innovation or keeping it as a trade secret. Typically, the analysis involves comparing the potential strength of patent protection that is likely...
Jeremiah Helm and Sean Murray’s Discuss Extension of Printed Matter Doctrine in Law360 Column
In their latest Law360 column discussing noteworthy Federal Circuit cases, partners Jeremiah Helm and Sean Murray examine the recent decision in Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., and how...
Knobbe Martens Advises Pacira BioSciences in Exclusive License Agreement with AmacaThera for Novel Long-Acting Analgesic
Agreement will support the development and commercialization of non-opioid therapy for postsurgical pain control IRVINE, Calif., November 4, 2025 – A team from Knobbe Martens advised Pacira BioSciences, Inc. in...
The USPTO’s Evolving Approach to Patent Eligibility: Insights from Director Squires’ AIPLA Address
On October 31, 2025, Director Squires spoke to the American Intellectual Property Law Association and provided a forceful statement on his view for the direction of patent law. Of particular...
